US Patent 7399866 Compounds, compositions, and methods
Patent 7399866 was granted and assigned to Cytokinetics on July, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+11 properties)
Infobox
Patent Inventor Names
Adam Lewis Tomasi0
Alex Muci0
Bradley Paul Morgan0
David J. Morgans, Jr.0
Erica Anne Kraynack0
Fady Malik0
Kathleen A. Elias0
Pu-Ping Lu0
Todd Tochimoto0
Whitney Walter Smith0
Xiangping Qian0
Edits on 14 Sep, 2023
Golden AI
Edits made to:
Article (+229 characters)
Article
Patent abstract
Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, are useful in the treatment of systolic heart failure including congestive heart failure.
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07399866 Compounds, compositions, and methods US Patent 7399866 Compounds, compositions, and methods
Infobox
Patent Number
073998660
Patent Number
73998660
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073998660
Date of Patent
July 15, 2008
0Patent Application Number
105415960
Date Filed
January 14, 2004
0Official Website
Patent Primary Examiner
Edits on 9 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 30 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07399866 Compounds, compositions, and methods
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07399866
Date of patent
July 15, 2008
Patent application number
10541596
Date Filed
January 14, 2004
Patent primary examiner
Find more entities like US Patent 7399866 Compounds, compositions, and methods
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
